References
- Brogard J M, Coumaros D, Franckhauser J, Stahl A, Stahl J. Enzymatic uricolysis: a study of the effect of a fungal urate-oxidase. Rev Eur Etud Clin Biol 1972; 14: 890–895
- Jeha S, Kantarjian H, Irwin D, Shen V, Shenoy S, Blaney S, et al. Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia 2005; 19: 34–38
- Coiffier B, Mounier N, Bologna S, Fermé C, Tilly H, Sonet A, et al. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma; results of the GRAAL1 (Groupe d'Etude del Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol 2003; 21: 4402–4406
- Browning L, Kruse J. Hemolysis and methemoglobinemia secondary to rasburicase administration. Ann Pharmacother 2005; 39: 1932–1935
- Mycyk M, Manaligod J, Sigg T, Erickson T. Toxikon Consortium, Illinois Poison Center, University of Illinois Hospital, University of Chicago Hosptial, Chicago, IL. Methemoglobinemia induced by routine urate oxidase administration. J Toxicol Clin Toxicol 2001; 39: 511
- Hoffman R. Hematology: Basic principles and practice. 4th ed. Churchill Livingstone, Philadelphia, PA 2005; 651
- Prchal J, Gregg X. Red cell enzymes. Hematology 2005; 1: 19–23
- Hamada Y, Kameyama Y, Lizuka T, Ishizaki T, Nishiyama T, Isshiki A. Methemoglobinemia from hydrogen peroxide in a patient with acatalasemia. Anesthesiology 2004; 101: 247–248
- Ford M D. Clinical toxicology. 1st ed. W.B. Saunders Company, Philadelphia, PA 2001; 215
- Sin D, Shafran S. Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals. J Acq Immune Defic Syn Human Retrovirol 1996; 12: 477–481
- Yim B, Sims-McCallum R, Chong P. Rasburicase for the treatment and prevention of hyperuricemia. Ann Pharmacother 2003; 37: 1047–1054